obesity drug news today glp-1 october 2025 oct 27 Weight loss with GLP-1 medicines does WHO Issues First Guidance on

While no studies show cancer causation, those with a history of cancer should avoid these compounds due to IGF-1s mitogenic properties

Key Takeaways for Providers Integrating medical weight loss peptides into your practice offers a profound opportunity to improve patient health

Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial

If you decide to explore this route, a quick reality check is important

The product is intended for scientific research and development purposes only

Because GHK-Cu is a photolabile copper(II) peptide complex, keep the entire blend light-protected throughout storage, reconstitution and aliquoting, and use amber or foil-wrapped vessels for aliquots